If fatigue , medication tolerance , or persistent GI distress has made pharmaceutical GLP-1 drugs unworkable, a probiotic approach offers a fundamentally different mechanism with a much milder side effect profile
Shots or pills, smart reminders, medication levels, and side effects over time
It will also pull up a number of labwork from the past, Im not sure how how back it goes
Preclinical models show that GLP-1 agonists can reduce neuroinflammation by dampening microglial activation and decreasing pro-inflammatory cytokines, suggesting potential applications in protecting against neurodegenerative diseases like Alzheimer's and Parkinson's disease
Fast-acting insulins start working in the body within 30 minutes of being injected
Anyone with type 1 diabetes already has underlying autoimmune issues, says Lala